BioSpace: Highlighted by Amylyx, the ALS Space is Gaining Momentum
ALS News Today: Cholesterol Transporter May Be Stronger Trigger of Sporadic ALS
RealTalk MS Podcast: Interview with Tisch MSRCNY Scientist, Dr. Roberto Alfonso
Mice injected with spinal fluid from ALS patients offer potential therapeutic target
MS News Today: Anti-CD20 Therapies Help Mount T-cell Response to COVID-19 Vaccines
Stem Cells Treatments Show Promise in MS (managedhealthcareexecutive.com)
RealTalk MS Podcast: Episode 250 featuring Dr. Saud Sadiq
Biospace: Research Shows Stem Cells Might Become a Game Changer for Multiple Sclerosis
The Joan Hamburg Show Director and Chief Research Scientist of the Tisch MS Research Center of New York, Dr. Saud A. Sadiq, talks with Joan Hamburg about MS and our Phase II stem cell trial.
NY Mag: Dr. Sadiq-Damage Control
521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.